Pharmaco-economic study and cost of care for chronic diseases: Case of Haemophilia in Morocco
Open Access
- 2 April 2020
- journal article
- Published by Heighten Science Publications Corporation in Journal of Advanced Pediatrics and Child Health
- Vol. 3 (1), 024-026
- https://doi.org/10.29328/journal.japch.1001013
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with InhibitorsThrombosis and Haemostasis, 2019
- Pharmacokinetics of Extended Half-Life Factor VIII Products By myPKFiTR Is Useful for Personalized Treatment in Children with Severe Hemophilia aBlood, 2019
- Chronic Inflammation as an Immunological Abnormality and Effectiveness of ExerciseBiomolecules, 2019
- L'engagement de la personne dans les soins de santé et services sociauxPublished by JSTOR ,2017
- Need for Prophylactic Treatment in Adult Haemophilia A PatientsTransfusion Medicine and Hemotherapy, 2009
- Genetic determinants of normal variation in coagulation factor (F) IX levels: genome‐wide scan and examination of the FIX structural geneJournal of Thrombosis and Haemostasis, 2006
- The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors OrganisationBritish Journal of Haematology, 2006
- The impact of prophylactic treatment on children with severe haemophiliaBritish Journal of Haematology, 1996